Access to innovative drugs and the National Reimbursement Drug List in China: Changing dynamics and future trends in pricing and reimbursement

ABSTRACTBackground and objectives: Multiple reforms aimed at improving the Chinese population’s health have been introduced in recent years, including several designed to improve access to innovative drugs. We sought to review current factors affecting access to innovative drugs in China and to anti...

詳細記述

書誌詳細

出版年:	Journal of Market Access & Health Policy
主要な著者:	Bérengère Macabeo, Liam Wilson, Jianwei Xuan, Ruichen Guo, Petar Atanasov, Linda Zheng, Clement François, Philippe Laramée
フォーマット:	論文
言語:	英語
出版事項:	MDPI AG 2023-12-01
主題:	National Reimbursement Drug List innovative drug access pricing reimbursement decision making health technology assessment
オンライン･アクセス:	https://www.tandfonline.com/doi/10.1080/20016689.2023.2218633